On Sunday, Arcellx, Inc. (NASDAQ:ACLX) revealed new data from its Phase 2 pivotal iMMagine-1 study of anitocabtagene autoleucel (anito-cel) in patients with relapsed or refractory multiple myeloma ...

Stifel Nicolaus analyst Benjamin Burnett maintained a Buy rating on Arcellx Inc (ACLX – Research Report) today and set a price target of ...

Arcellx had a negative return on equity of 8.28% and a negative net margin of 25.94%. As a group, equities research analysts expect that Arcellx will post -1.58 earnings per share for the current ...

Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) was the target of a significant increase in short interest during the month of December.As of December 31st, there was short interest totalling ...

根据最近的SEC文件显示，Arcellx, Inc.（NASDAQ:ACLX）的董事Kavita Patel近期减持了其持有的部分公司股份。Patel于2025年2月4日以每股64.57美元的价格出售了1,500股Arcellx普通股。这笔交易总额为96,854美元，是根据2024年3月28日制定的Rule 10b5-1交易计划执行的。该股票表现强劲 ...

O n Monday, Stifel analysts reiterated their Buy rating for Arcellx Inc. (NASDAQ: ACLX) with a consistent price target of $122.00. Currently trading at $64.01, the stock has significant upside ...

For the first time in almost 20 years, Walmart has a new logo. The international retailer describes it as a “a comprehensive brand refresh,” but the online world hasn’t been quite so kind to ...

Operator Good afternoon, everyone, and welcome to Gilead's fourth quarter and full year 2024 earnings conference call. My ...

Arcellx's anito-cel shows promising efficacy and safety in multiple myeloma, with a 97% response rate and low neurotoxicity, potentially differentiating it in a crowded market. Financially robust ...